Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2026.
Genomenon's investors include Michigan Rise, BroadOak Capital Partners, Spring Mountain Capital, University of Michigan, Beringea.
Genomenon is headquartered in Ann Arbor, United States.
Genomenon develops software tools to rapidly and autonomously prioritize data points for decision-making.
Genomenon is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Genomenon — Funding & Investors." VCBacked, July 30, 2026, https://www.vcbacked.co/company/genomenon. Accessed September 14, 2026.
VCBacked. (2026). Genomenon — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/genomenon
{{cite web |title=Genomenon — Funding & Investors |url=https://www.vcbacked.co/company/genomenon |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated